# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001437749-26-013362
Filing Date
2026-04-27
Accepted
2026-04-27 06:21:13
Documents
8
Period of Report
2026-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | athe20260427_6k.htm | 6-K | 10818
2 | EXHIBIT 99.1 | ex_951141.htm | EX-99.1 | 5295
3 |  | page01.jpg | GRAPHIC | 253504
4 |  | page02.jpg | GRAPHIC | 125799
5 |  | page03.jpg | GRAPHIC | 108017
6 |  | page04.jpg | GRAPHIC | 202558
7 |  | page05.jpg | GRAPHIC | 224627
8 |  | page06.jpg | GRAPHIC | 102337
| Complete submission text file | 0001437749-26-013362.txt |  | 1418106

Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 26896417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)